Search results for: 'research area tyrosine kinase insulin receptor'
- A3167 AM-095 free baseTarget: LPA ReceptorsSummary: Potent LPA1 receptor antagonist
- BA6337 RezivertinibSummary: Rezivertinib (BPI-7711) is an orally effective, highly selective and irreversible third-generation tyrosine kinase inhibitor (TKI).
- BA3198 S116836Summary: S116836 is a potent, orally active tyrosine kinase inhibitor (TKI) that blocks both wild-type and T315I.
- BA9025 CevidoplenibSummary: Cevidoplenib (SKI-O-703) is an orally active spleen tyrosine kinase inhibitor with potential anti-inflammatory and immunomodulatory effects.
- A3500 IRAK inhibitor 12 CitationTarget: IRAKSummary: IRAK-4 inhibitor
- BA8110 MY10Summary: MY10 is a potent and orally active receptor protein tyrosine phosphatase inhibitor.
- B7302 HEPESSummary: Multi purpose buffer used in biological research
- B7303 HEPES Sodium saltSummary: Multi purpose buffer used in biological research
- BA7165 MK204Summary: An aldose reductase inhibitor used in diabetes research.
- BA4203 PU-H54Summary: PU-H54 is a selective inhibitor for breast cancer research.